14-day Premium Trial Subscription Try For FreeTry Free
NYSE:MSTX
Delisted

Mast Therapeutics, Inc Fund Price (Quote)

New York Stock Exchange
Open Broker Account
$0.130
+0 (+0%)
At Close: Jan 16, 2018
Forecast Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 16th Jan 2018 MSTX stock ended at $0.130. During the day the stock fluctuated 0% from a day low at $0.130 to a day high of $0.130.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Mast Therapeutics, Inc prices

Date Open High Low Close Volume
Sep 23, 2016 $0.140 $0.140 $0.130 $0.130 23 099 500
Sep 22, 2016 $0.130 $0.150 $0.130 $0.130 48 063 000
Sep 21, 2016 $0.110 $0.140 $0.100 $0.120 125 545 000
Sep 20, 2016 $0.580 $0.600 $0.570 $0.590 4 565 800
Sep 19, 2016 $0.590 $0.610 $0.570 $0.590 3 927 500
Sep 16, 2016 $0.590 $0.620 $0.520 $0.620 5 903 300
Sep 15, 2016 $0.520 $0.590 $0.500 $0.570 7 566 600
Sep 14, 2016 $0.490 $0.520 $0.400 $0.490 6 116 100
Sep 13, 2016 $0.590 $0.600 $0.350 $0.510 17 640 300
Sep 12, 2016 $0.600 $0.620 $0.540 $0.580 6 131 500
Sep 09, 2016 $0.650 $0.650 $0.560 $0.610 6 255 600
Sep 08, 2016 $0.690 $0.700 $0.620 $0.630 6 854 900
Sep 07, 2016 $0.640 $0.680 $0.610 $0.650 8 014 300
Sep 06, 2016 $0.610 $0.710 $0.580 $0.650 20 416 600
Sep 02, 2016 $0.530 $0.570 $0.480 $0.550 8 439 900
Sep 01, 2016 $0.440 $0.600 $0.440 $0.520 18 637 400
Aug 31, 2016 $0.430 $0.440 $0.430 $0.440 2 079 400
Aug 30, 2016 $0.420 $0.440 $0.410 $0.430 2 566 900
Aug 29, 2016 $0.410 $0.410 $0.400 $0.410 1 660 200
Aug 26, 2016 $0.390 $0.420 $0.380 $0.390 1 360 300
Aug 25, 2016 $0.400 $0.410 $0.400 $0.400 1 479 300
Aug 24, 2016 $0.400 $0.420 $0.400 $0.400 1 550 600
Aug 23, 2016 $0.400 $0.420 $0.400 $0.420 1 398 300
Aug 22, 2016 $0.400 $0.430 $0.400 $0.410 2 086 600
Aug 19, 2016 $0.410 $0.410 $0.400 $0.400 1 258 700
Click to get the best stock tips daily for free!

About Mast Therapeutics, Inc

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with significant unmet needs. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure. It also develops AIR001, a sodium nitrite solution for intermittent inhalation via nebulizer, as well as for the treatment of hear... MSTX Profile

Golden Star

Ticker Date Change Price
VCSH May 03 0.0130% $76.93
BNDX May 03 0.349% $48.68
BBCA May 03 1.26% $65.44
ISTB May 03 0.0425% $47.11
ADTH May 03 5.56% $3.24
WMT May 03 1.34% $59.82
UNP May 03 0.84% $240.36
INGR May 03 1.75% $114.56
ASH May 03 2.26% $95.85
WU May 03 0.449% $13.37
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT